Browsing Tag
Form 20-F
1 post
Can Moolec avoid delisting? Nasdaq hearing set for December 18
Moolec faces a critical Nasdaq compliance hearing over its delayed 20-F report. Explore what this means for MLEC investors and the future of molecular farming.